COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213 | -42.1% | 57 | -99.8% | 0.00% | -100.0% |
| Q4 2022 | $368 | -99.9% | 37,892 | -22.0% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | -2.2% | 48,600 | -11.0% | 0.00% | 0.0% |
| Q2 2022 | $416,000 | -23.0% | 54,580 | +2.1% | 0.00% | -25.0% |
| Q1 2022 | $540,000 | -20.4% | 53,455 | -3.1% | 0.00% | -20.0% |
| Q4 2021 | $678,000 | -29.9% | 55,193 | -4.1% | 0.01% | -16.7% |
| Q3 2021 | $967,000 | +6.7% | 57,578 | -7.7% | 0.01% | +20.0% |
| Q2 2021 | $906,000 | -5.6% | 62,368 | -3.3% | 0.01% | -16.7% |
| Q1 2021 | $960,000 | -21.7% | 64,472 | -3.6% | 0.01% | -25.0% |
| Q4 2020 | $1,226,000 | +6.1% | 66,889 | +1.9% | 0.01% | 0.0% |
| Q3 2020 | $1,155,000 | -2.1% | 65,653 | +2.1% | 0.01% | -11.1% |
| Q2 2020 | $1,180,000 | – | 64,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |